scispace - formally typeset
M

Mauricio Pérez

Researcher at Pontifical Xavierian University

Publications -  16
Citations -  439

Mauricio Pérez is an academic researcher from Pontifical Xavierian University. The author has contributed to research in topics: Cutaneous leishmaniasis & Meglumine antimoniate. The author has an hindex of 11, co-authored 16 publications receiving 397 citations.

Papers
More filters
Journal ArticleDOI

Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children

TL;DR: Miltefosine is noninferior to meglumine antimoniate for treatment of pediatric cutaneous leishmaniasis caused by Leishmania (Viannia) species and advantages of oral administration and low toxicity favor use of miltefOSine in children.
Journal ArticleDOI

Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment

TL;DR: The presence of Leishmania parasites in the unaffected skin and peripheral-blood monocytes of a high proportion of patients even after treatment and the acquisition of infection by sand flies support the plausibility of anthroponotic transmission of American cutaneous leishmaniasis.
Journal ArticleDOI

Phlebotomine Vector Ecology in the Domestic Transmission of American Cutaneous Leishmaniasis in Chaparral, Colombia

TL;DR: Phlebotomine vector ecology was studied in the largest recorded outbreak of American cutaneous leishmaniasis in Colombia in 2004, and large differences were observed in population abundance between the two townships evaluated.
Journal ArticleDOI

Seroprevalencia de infección por Leptospira en habitantes de barrios periféricos de Cali

TL;DR: In this article, a seroprevalencia de infeccion por leptospira in humanos, identificar the reactividad serologica and explorar factores asociados with the seropositividad.
Journal ArticleDOI

Novel Approach to In Vitro Drug Susceptibility Assessment of Clinical Strains of Leishmania spp.

TL;DR: Measurement of the reduction of parasite burden at a single predetermined drug concentration under standardized conditions provides an efficient and reliable strategy for susceptibility evaluation and monitoring of clinical strains of Leishmania.